US FDA approved Biotronik SE & Co. KG Orsiro cobalt chromium bioresorbable-polymer, sirolimus-eluting, ultra-thin strut coronary stent and the company has launched it in the US immediately, the company announced Feb. 22.
Orsiro earned a CE mark in 2011 and has been used in over a million patients, according to the company.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?